Patent that has brought over $350 million to U of M is about to end

The royalties from an HIV drug called Ziagen will trickle to zero in 2013, which means less money for new research.
Author:
Publish date:
Social count:
0

The royalties from an HIV drug called Ziagen will trickle to zero in 2013, which means less money for new research.

Related

U of M wins grant to develop new type of hazelnut

The U.S. Department of Agriculture is pledging nearly $1 million to the school to develop a new type of hazelnut that can thrive in Minnesota's climate. U researchers believe the hazelnut could become a major money-making crop for Minnesota in the next 10 years.

U of M researcher: Bulimia changes the brain

Doctors say when there’s an increase in binging episodes, the brain's reward system comes less responsive. That means disorders like bulimia not only causes psychological issues but also biological effects that alter the brain’s reward system.

U of M's controversial website featured at global AIDS event

Four years ago, researchers at the University of Minnesota developed a sexually explicit, interactive gaming and information website called Sexpulse to educate gay men about safer sex and HIV. The provocative experiment came under fire from social conservatives, but the project survived. This week the team will present its research on HIV and social media at the International AIDS Conference in Washington, D.C.

U of M church up for sale

Officials want to complete the sale of the University Lutheran Chapel by the end of the year. The congregation is trying to raise money to buy the church. The minimum price is set at $3.2 million.

U of M wants $170M from state

A formal request from the University of Minnesota regents will ask the state Legislature for $170 million. The money will be spent on building and renovation projects. The U of M plans to contribute nearly $40 million in addition to the state funding for a university budget of $209 million.

Next Up